{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,6]],"date-time":"2024-10-06T01:15:18Z","timestamp":1728177318919},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Second Affiliated Hospital of Xi\u2019an Jiaotong University Research Foundation","award":["2020MS-08"],"award-info":[{"award-number":["2020MS-08"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Vitiligo is the most common depigmenting disorder to which both genetic and environmental factors contribute. The aim of the current work was to evaluate the relationship between polymorphisms of the gene nuclear receptor subfamily 1 Group H member 3 (<jats:italic>NR1H3<\/jats:italic>) and the risk of vitiligo and phototherapy effects in the Chinese Han population. Two independent samples were enrolled to form the discovery set (comprised of 1668 nonsegmental vitiligo [NSV] patients and 2542 controls) and the validation set (comprised of 745 NSV patients and 1492 controls). A total of 13 tag single nucleotide polymorphisms (SNPs) were genotyped in the samples from the discovery stage. SNPs that achieved nominal significance were validated in another independent sample set. The serum level of NR1H3 protein was assayed using enzyme-linked immunosorbent assay kits in the validation set. Genetic association analysis was carried out at allelic and genotypic levels. The therapeutic effects of significant SNPs were examined in the validation set. The SNP rs3758672 was significantly associated with NSV. The A allele was correlated with NSV risk and poorer therapeutic effects. The A allele was strongly correlated with the increased level of serum NR1H3 in both controls and patients. In summary, SNP rs3758672 in <jats:italic>NR1H3<\/jats:italic> was significantly associated with both disease susceptibility and individualized therapeutic effects of NSV in study participants with Han Chinese ancestry.<\/jats:p>","DOI":"10.1038\/s41598-023-30047-7","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T11:30:05Z","timestamp":1677756605000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Contributions of NR1H3 genetic polymorphisms to susceptibility and effects of narrowband UVB phototherapy to nonsegmental vitiligo"],"prefix":"10.1038","volume":"13","author":[{"given":"Meifeng","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuning","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengxiang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,28]]},"reference":[{"key":"30047_CR1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s12016-021-08868-z","volume":"61","author":"Y Wang","year":"2021","unstructured":"Wang, Y., Li, S. & Li, C. Clinical features, immunopathogenesis, and therapeutic strategies in vitiligo. Clin. Rev. Allergy Immunol. 61, 299\u2013323. https:\/\/doi.org\/10.1007\/s12016-021-08868-z (2021).","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"1","key":"30047_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.2340\/00015555-1397","volume":"93","author":"X Wang","year":"2013","unstructured":"Wang, X. et al. Prevalence and clinical profile of vitiligo in China: A community-based study in six cities. Acta Derm. Venereol. 93(1), 62\u201365. https:\/\/doi.org\/10.2340\/00015555-1397 (2013).","journal-title":"Acta Derm. Venereol."},{"key":"30047_CR3","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","volume":"25","author":"K Ezzedine","year":"2012","unstructured":"Ezzedine, K. et al. Revised classification\/nomenclature of vitiligo and related issues: The Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res. 25, E1-13. https:\/\/doi.org\/10.1111\/j.1755-148X.2012.00997.x (2012).","journal-title":"Pigment Cell Melanoma Res."},{"key":"30047_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2174\/138920010791526105","volume":"11","author":"L Guerra","year":"2010","unstructured":"Guerra, L., Dellambra, E., Brescia, S. & Raskovic, D. Vitiligo: Pathogenetic hypotheses and targets for current therapies. Curr. Drug Metab. 11, 451\u2013467. https:\/\/doi.org\/10.2174\/138920010791526105 (2010).","journal-title":"Curr. Drug Metab."},{"key":"30047_CR5","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jaci.2017.07.011","volume":"140","author":"ML Frisoli","year":"2017","unstructured":"Frisoli, M. L. & Harris, J. E. Vitiligo: Mechanistic insights lead to novel treatments. J. Allergy Clin. Immunol. 140, 654\u2013662. https:\/\/doi.org\/10.1016\/j.jaci.2017.07.011 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"30047_CR6","doi-asserted-by":"publisher","first-page":"102932","DOI":"10.1016\/j.autrev.2021.102932","volume":"21","author":"BK Khaitan","year":"2022","unstructured":"Khaitan, B. K. & Sindhuja, T. Autoimmunity in vitiligo: Therapeutic implications and opportunities. Autoimmun. Rev. 21, 102932. https:\/\/doi.org\/10.1016\/j.autrev.2021.102932 (2022).","journal-title":"Autoimmun. Rev."},{"key":"30047_CR7","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1038\/sj.jid.5700953","volume":"127","author":"Y Jin","year":"2007","unstructured":"Jin, Y., Birlea, S. A., Fain, P. R. & Spritz, R. A. Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population. J. Investig. Dermatol. 127, 2558\u20132562. https:\/\/doi.org\/10.1038\/sj.jid.5700953 (2007).","journal-title":"J. Investig. Dermatol."},{"key":"30047_CR8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.smim.2006.03.008","volume":"18","author":"N Bottini","year":"2006","unstructured":"Bottini, N., Vang, T., Cucca, F. & Mustelin, T. Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Semin. Immunol. 18, 207\u2013213. https:\/\/doi.org\/10.1016\/j.smim.2006.03.008 (2006).","journal-title":"Semin. Immunol."},{"key":"30047_CR9","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.cell.2006.06.049","volume":"126","author":"AL Bookout","year":"2006","unstructured":"Bookout, A. L. et al. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126, 789\u2013799. https:\/\/doi.org\/10.1016\/j.cell.2006.06.049 (2006).","journal-title":"Cell"},{"key":"30047_CR10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1194\/jlr.R800001-JLR200","volume":"49","author":"M Schmuth","year":"2008","unstructured":"Schmuth, M., Jiang, Y. J., Dubrac, S., Elias, P. M. & Feingold, K. R. Thematic review series: Skin lipids. Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology. J. Lipid Res. 49, 499\u2013509. https:\/\/doi.org\/10.1194\/jlr.R800001-JLR200 (2008).","journal-title":"J. Lipid Res."},{"key":"30047_CR11","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/sj.jid.5700046","volume":"126","author":"MQ Man","year":"2006","unstructured":"Man, M. Q. et al. Basis for improved permeability barrier homeostasis induced by PPAR and LXR activators: Liposensors stimulate lipid synthesis, lamellar body secretion, and post-secretory lipid processing. J. Investig. Dermatol. 126, 386\u2013392. https:\/\/doi.org\/10.1038\/sj.jid.5700046 (2006).","journal-title":"J. Investig. Dermatol."},{"key":"30047_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1600-0625.2009.00940.x","volume":"19","author":"R Kumar","year":"2010","unstructured":"Kumar, R., Parsad, D., Kaul, D. & Kanwar, A. Liver X receptor expression in human melanocytes, does it have a role in the pathogenesis of vitiligo?. Exp. Dermatol. 19, 63\u201364. https:\/\/doi.org\/10.1111\/j.1600-0625.2009.00940.x (2010).","journal-title":"Exp. Dermatol."},{"key":"30047_CR13","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/exd.12017","volume":"21","author":"R Kumar","year":"2012","unstructured":"Kumar, R., Parsad, D., Kanwar, A. & Kaul, D. Altered levels of LXR-alpha: Crucial implications in the pathogenesis of vitiligo. Exp. Dermatol. 21, 853\u2013858. https:\/\/doi.org\/10.1111\/exd.12017 (2012).","journal-title":"Exp. Dermatol."},{"key":"30047_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mgene.2016.02.001","volume":"8","author":"S Agarwal","year":"2016","unstructured":"Agarwal, S. et al. Liver X Receptor-alpha polymorphisms (rs11039155 and rs2279238) are associated with susceptibility to vitiligo. Meta Gene 8, 33\u201336. https:\/\/doi.org\/10.1016\/j.mgene.2016.02.001 (2016).","journal-title":"Meta Gene"},{"key":"30047_CR15","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1111\/jocd.13772","volume":"20","author":"WA Shehata","year":"2021","unstructured":"Shehata, W. A., Maraee, A., Mehesin, M., Tayel, N. & Azmy, R. Genetic polymorphism of liver X receptor gene in vitiligo: Does it have an association?. J. Cosmet. Dermatol. 20, 1906\u20131914. https:\/\/doi.org\/10.1111\/jocd.13772 (2021).","journal-title":"J. Cosmet. Dermatol."},{"key":"30047_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.4103\/0378-6323.26722","volume":"72","author":"U Bhor","year":"2006","unstructured":"Bhor, U. & Pande, S. Scoring systems in dermatology. Indian J. Dermatol. Venereol. Leprol. 72, 315\u2013321. https:\/\/doi.org\/10.4103\/0378-6323.26722 (2006).","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"30047_CR17","doi-asserted-by":"publisher","first-page":"750342","DOI":"10.1155\/2011\/750342","volume":"2011","author":"T Kawakami","year":"2011","unstructured":"Kawakami, T. & Hashimoto, T. Disease severity indexes and treatment evaluation criteria in vitiligo. Dermatol. Res. Pract. 2011, 750342. https:\/\/doi.org\/10.1155\/2011\/750342 (2011).","journal-title":"Dermatol. Res. Pract."},{"key":"30047_CR18","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell, S. et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559\u2013575. https:\/\/doi.org\/10.1086\/519795 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"30047_CR19","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.ip71","author":"JC Barrett","year":"2009","unstructured":"Barrett, J. C. Haploview: Visualization and analysis of SNP genotype data. Cold Spring Harb. Protoc. https:\/\/doi.org\/10.1101\/pdb.ip71 (2009).","journal-title":"Cold Spring Harb. Protoc."},{"key":"30047_CR20","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"Consortium, G. T.","year":"2013","unstructured":"Consortium, G. T. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580\u2013585. https:\/\/doi.org\/10.1038\/ng.2653 (2013).","journal-title":"Nat. Genet."},{"key":"30047_CR21","doi-asserted-by":"publisher","first-page":"D1005","DOI":"10.1093\/nar\/gky1120","volume":"47","author":"A Buniello","year":"2019","unstructured":"Buniello, A. et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 47, D1005\u2013D1012. https:\/\/doi.org\/10.1093\/nar\/gky1120 (2019).","journal-title":"Nucleic Acids Res."},{"key":"30047_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-022-02348-w","author":"YE Youssef","year":"2022","unstructured":"Youssef, Y. E., Eldegla, H. E. A., Elmekkawy, R. S. M. & Gaballah, M. A. Evaluation of vitamin D receptor gene polymorphisms (ApaI and TaqI) as risk factors of vitiligo and predictors of response to narrowband UVB phototherapy. Arch. Dermatol. Res. https:\/\/doi.org\/10.1007\/s00403-022-02348-w (2022).","journal-title":"Arch. Dermatol. Res."},{"key":"30047_CR23","doi-asserted-by":"publisher","first-page":"231","DOI":"10.4103\/ijd.IJD_520_17","volume":"63","author":"OA Bakry","year":"2018","unstructured":"Bakry, O. A., Shoeib, M., El Kady, N. & Attalla, S. Re-appraisal of keratinocytes\u2019 role in vitiligo pathogenesis. Indian J. Dermatol. 63, 231\u2013240. https:\/\/doi.org\/10.4103\/ijd.IJD_520_17 (2018).","journal-title":"Indian J. Dermatol."},{"issue":"1","key":"30047_CR24","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1600-0625.2009.00940.x","volume":"19","author":"R Kumar","year":"2010","unstructured":"Kumar, R., Parsad, D., Kaul, D. & Kanwar, A. J. Liver X receptor expression in human melanocytes, does it have a role in the pathogenesis of vitiligo?. Exp. Dermatol. 19(1), 62\u201364 (2010).","journal-title":"Exp. Dermatol."},{"issue":"11","key":"30047_CR25","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/exd.12017","volume":"21","author":"R Kumar","year":"2012","unstructured":"Kumar, R., Parsad, D., Kanwar, A. J. & Kaul, D. Altered levels of LXR-\u03b1: Crucial implications in the pathogenesis of vitiligo. Exp. Dermatol. 21(11), 853\u2013858 (2012).","journal-title":"Exp. Dermatol."},{"key":"30047_CR26","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41586-021-03855-y","volume":"597","author":"Q Wang","year":"2021","unstructured":"Wang, Q. et al. Rare variant contribution to human disease in 281,104 UK Biobank exomes. Nature 597, 527\u2013532. https:\/\/doi.org\/10.1038\/s41586-021-03855-y (2021).","journal-title":"Nature"},{"key":"30047_CR27","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.schres.2019.09.015","volume":"215","author":"F Guan","year":"2020","unstructured":"Guan, F. et al. Relationship of SNAP25 variants with schizophrenia and antipsychotic-induced weight change in large-scale schizophrenia patients. Schizophr. Res. 215, 250\u2013255 (2020).","journal-title":"Schizophr. Res."},{"key":"30047_CR28","doi-asserted-by":"publisher","first-page":"114790","DOI":"10.1016\/j.psychres.2022.114790","volume":"316","author":"H Wang","year":"2022","unstructured":"Wang, H. et al. Evaluation of Adenosine A2A receptor gene polymorphisms as risk factors of methamphetamine use disorder susceptibility and predictors of craving degree. Psychiatry Res. 316, 114790 (2022).","journal-title":"Psychiatry Res."},{"key":"30047_CR29","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.schres.2018.10.011","volume":"206","author":"W Han","year":"2018","unstructured":"Han, W. et al. Relationship of common variants in CHRNA5 with early-onset schizophrenia and executive function. Schizophr. Res. 206, 407\u2013412 (2018).","journal-title":"Schizophr. Res."},{"key":"30047_CR30","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ajmg.b.32773","volume":"183","author":"F Guan","year":"2020","unstructured":"Guan, F. et al. Evaluation of the relationships of the WBP1L gene with schizophrenia and the general psychopathology scale based on a case-control study. Am. J. Med. Genet. B Neuropsychiatr. Genet. 183, 164\u2013171 (2020).","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"30047_CR31","first-page":"1","volume":"188","author":"F Guan","year":"2021","unstructured":"Guan, F. et al. Integrative omics of schizophrenia: From genetic determinants to clinical classification and risk prediction. Mol. Psychiatry. 188, 1\u201314 (2021).","journal-title":"Mol. Psychiatry."},{"issue":"2","key":"30047_CR32","doi-asserted-by":"publisher","first-page":"bbac046","DOI":"10.1093\/bib\/bbac046","volume":"23","author":"C Shen","year":"2022","unstructured":"Shen, C. et al. DLRAPom: A hybrid pipeline of optimized XGBoost-guided integrative multiomics analysis for identifying targetable disease-related lncRNA\u2013miRNA\u2013mRNA regulatory axes. Brief Bioinform. 23(2), bbac046 (2022).","journal-title":"Brief Bioinform."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-30047-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-30047-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-30047-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T11:30:13Z","timestamp":1677756613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-30047-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,28]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["30047"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-30047-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,28]]},"assertion":[{"value":"23 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3384"}}